B LYNNE PARSHALL
CIK 1073385 · COO · last filed 2026-06-01
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$4.87M
Companies
7
Total Filings
170
Lifetime Open-Market Net
-$93.07M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CYTK | Director | 15,784 | $70.15 | $1.11M | -$7.72M | 38 | 2026-06-01 |
| IONS | Director | 51,344 | $73.28 | $3.76M | -$17.94M | 43 | 2026-04-17 |
| FHTX | Director | — | $4.18 | — | $0 | 4 | 2025-06-17 |
| AKCEA THERAPEUTICS, INC. (AKCA) Delisted | Director | — | — | — | $0 | 5 | 2020-10-13 |
| IONIS PHARMACEUTICALS INC (ISIS) Delisted | COO & Secretary | 13,143 | — | — | -$24.74M | 59 | 2015-11-09 |
| Regulus Therapeutics Inc. (RGLS) Delisted | Director | 12,565,805 | $8.16 | $102.54M | -$42.66M | 17 | 2014-11-05 |
| CARDIODYNAMICS INTERNATIONAL CORP (CDIC) Delisted | Director | 0 | — | — | $0 | 4 | 2009-08-14 |
Recent Filings · Page 11 of 17
170 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2014-09-26 | Regulus Therapeutics Inc. (RGLS) Delisted | Sell (S) | −17,500 | -$124.7K | EDGAR |
| 2014-09-19 | Regulus Therapeutics Inc. (RGLS) Delisted | Sell (S) | −15,400 | -$112.6K | EDGAR |
| 2014-09-12 | Regulus Therapeutics Inc. (RGLS) Delisted | Sell (S) | −17,800 | -$139.8K | EDGAR |
| 2014-09-05 | Regulus Therapeutics Inc. (RGLS) Delisted | Sell (S) | −20,100 | -$142.2K | EDGAR |
| 2014-09-04 | IONIS PHARMACEUTICALS INC (ISIS) Delisted | Mixed | — | -$332.9K | EDGAR |
| 2014-08-29 | Regulus Therapeutics Inc. (RGLS) Delisted | Sell (S) | −10,000 | -$70.0K | EDGAR |
| 2014-08-22 | Regulus Therapeutics Inc. (RGLS) Delisted | Sell (S) | −21,500 | -$148.2K | EDGAR |
| 2014-08-15 | Regulus Therapeutics Inc. (RGLS) Delisted | Sell (S) | −10,900 | -$76.5K | EDGAR |
| 2014-08-08 | Regulus Therapeutics Inc. (RGLS) Delisted | Sell (S) | −15,200 | -$104.4K | EDGAR |
| 2014-08-01 | Regulus Therapeutics Inc. (RGLS) Delisted | Sell (S) | −10,700 | -$68.0K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.